Preeti P. John

Preeti P. John

Auto-generated profile, based on publicly available information

Preeti P. John

The Kidney and Urinary Tract Center, Abigail Wexner Research Institute at Nationwide Children’s Hospital, Columbus, USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 May 2022 in Journal of Diabetes Research
Verified
Journal Article
Open access
PDF file
Santosh PaudelSantosh Paudel
Santosh Paudel
PJPreeti P. John
Preeti P. John
SPSeyedeh Leila Poorbaghi
Seyedeh Leila Poorbaghi
TRTara M. Randis
Tara M. Randis
RKRitwij Kulkarni
Ritwij Kulkarni
This systematic review addresses the central research question, “what is known from the published, peer-reviewed literature about the impact of diabetes on the risk of bacterial urinary tract infections (UTI)?” We examine the results from laboratory studies where researchers have successfully adapted mouse models of diabetes to study the pathophysiology of ascending UTI. These studies have identified molecular and cellular effectors shaping immune defenses against infection of the diabetic urinary tract. In addition, we present evidence from clinical studies that in addition to diabetes, female gender, increased age, and diabetes-associated hyperglycemia, glycosuria, and immune impairment are important risk factors which further increase the risk of UTI in diabetic individuals. Clinical studies also show that the uropathogenic genera causing UTI are largely similar between diabetic and nondiabetic individuals, although diabetes significantly increases risk of UTI by drug-resistant uropathogenic bacteria.

23 July 2020 in The Journal of Infectious Diseases
Verified
Journal Article
Closed access
PJPreeti P John
Preeti P John
BBBrady C Baker
Brady C Baker
Santosh PaudelSantosh Paudel
Santosh Paudel
LNLauren C Nassour-Caswell
Lauren C Nassour-Caswell
HCHayden Cagle
Hayden Cagle
RKRitwij Kulkarni
Ritwij Kulkarni
To explore whether glycosuria induces virulence of uropathogens, in turn facilitating urinary tract infection (UTI), we exposed group B Streptococcus (GBS) strain 10/84 to human urine plain or with 300 mg/dL glucose (mimicking moderate glycosuria). Exposure to moderate glycosuria significantly augmented bacterial growth, kidney bacterial burden in a mouse model of ascending UTI, and virulence characteristics and expression of corresponding genes. Exposure to glycosuria increased GBS adherence to human bladder epithelial cell line and expression of corresponding PI2a fimbrial gene, antimicrobial peptide LL-37 resistance and bacterial surface charge modulating dltA, and GBS hemolytic ability and expression of genes encoding pore-forming toxins.

26 February 2026 in Nature Reviews Urology
Verified
Journal Article
Closed access
PDF file
PJPreeti P. John
Preeti P. John
LMLaura Mike
Laura Mike
IMIndira U. Mysorekar
Indira U. Mysorekar
JRJuan de Dios Ruiz-Rosado
Juan de Dios Ruiz-Rosado
MCMenna Clatworthy
Menna Clatworthy
BBBrian Becknell
Brian Becknell